Search

Made available in DSpace on 2021-06-25T10:31:06Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Objective: To compare pulse pressure variation (PPV) and systolic pressure variation (SPV) measured from a peripheral artery to predict fluid responsiveness in anesthetized healthy dogs. Study design: Prospective study. Animals: A total of 39 dogs (13.8–26.8 kg) anesthetized with isoflurane for elective ovariohysterectomy. Methods: Ventilation was controlled (tidal volume 12 mL kg–1; 40% inspiratory pause). PPV and SPV were recorded from a dorsal pedal artery catheter using an automated algorithm. A fluid challenge (FC) with lactated Ringer's solution (20 mL kg–1 over 15 minutes) was administered once (21 animals) or twice (18 animals) before surgery. Increases in transpulmonary thermodilution stroke volume index > 15% from values recorded before each FC defined responders to volume expansion. Final fluid responsiveness status was based on the response to single FC or second FC. Predictive ability of PPV and SPV was compared by receiver operating characteristic (ROC) curve analysis and by the range of cut-off values associated with uncertain results (gray zone). Results: All animals after the single FC were responders; all animals administered two FCs were nonresponders after the second FC. The area under the ROC curve (AUROC) of PPV (0.968) did not differ from that of SPV (0.937) (p = 0.45). Best cut-off thresholds to discriminate responders from nonresponders were >11.7% (PPV) and >7.4 mmHg (SPV). The gray zone of PPV and SPV was 8.2–14.6% and 7.0–7.4 mmHg, respectively. The percentage of animals with PPV and SPV values within the gray zone was less for SPV (10.2%) than for PPV (30.8%). Conclusions and clinical relevance: PPV and SPV obtained from the dorsal pedal artery are useful predictors of fluid responsiveness in dogs. Using an automated algorithm, SPV may more accurately predict fluid responsiveness than PPV, with responders identifiable by PPV > 14.6% and SPV > 7.4 mmHg. Faculdade de Medicina Universidade Estadual Paulista (UNESP) Faculdade de Medicina Veterinária e Zootecnia Universidade Estadual Paulista (UNESP) Faculdade de Medicina Universidade Estadual Paulista (UNESP) Faculdade de Medicina Veterinária e Zootecnia Universidade Estadual Paulista (UNESP) FAPESP: 2014/25115-8

Several studies have evaluated the association between a history of type 2 diabetes (T2D) and risk of breast cancer (BC), with controversial results. However, information regarding the population-attributable risk percent (PAR%) remains scarce. Objective: To estimate the association and the PAR% for BC and T2D, lifestyle and gynecologic factors in women in Mexico City.This case-control study was performed from May-December 2020. Women40 years of age, from Mexico City, with a confirmed diagnosis for BC were included as cases. Controls were women with a BIRADS 1 or 2 mammography or an ultrasound clear of any BC suggestive findings.A total of 134 cases and 134 controls were included. A higher risk for BC was identified among women who did not perform routine physical activity and those who had a history of hormonal contraceptive use5 years. The use of hormone replacement therapy (HRT) was associated with an odds ratio (OR) of 5.0 (p = 0.22) in the first model. After adjustment, HRT was associated with an OR of 2.92 (p=0.492) in the second and an OR of 3.6 (p = 0.753) in the third model. T2D was associated with an OR of 1.04 (p = 0.96) in the first model; an OR of 0.65 (p = 0.65) in the second model and an OR of RMa 0.75(p = 0.79) for the third model.In this case-control study, there was no significant association identified between a T2D diagnosis and BC.diversas investigaciones han evaluado el riesgo de cáncer de mama (CaMa) asociado a diabetes tipo 2 (DT2) con resultados inconsistentes. Pocas investigaciones han evaluado el porcentaje de riesgo atribuible a la población (PAR%).estimar la asociación y el PAR% para CaMa por DT2, así como los factores del estilo de vida y ginecológicos en mujeres de la Ciudad de México.estudio de casos y controles, realizado de mayo a diciembre de 2020. Se incluyeron mujeres40 años, de la Ciudad de México, con diagnóstico confirmado de CaMa. Los controles fueron mujeres con una mastografía BIRADS 1 o 2, o ultrasonido mamario sin datos sugestivos de CaMa.se incluyeron en total 134 casos y 134 controles. Se identificó un mayor riesgo de CaMa en aquellas mujeres que no realizan actividad física y con el uso de anticonceptivos5 años. El uso de terapia de reemplazo hormonal (TRH) se asoció con una razón de momios ajustada (RMa) de 5.0, p = 0.22 en el modelo 1. Conforme se ajustan los modelos, la TRH para el modelo 2 tuvo una RMa de 2.92, p = 0.492 y en el modelo 3 una RMa de 3.6 p = 0.753. La presencia de diabetes se asoció a una RMa de 1.04, p = 0.96 en el modelo 1; RMa de 0.65, p = 0.65 en el modelo 2 y una RMa de 0.75, p = 0.79 en el modelo 3.en este estudio de casos y controles no se encontró asociación entre el diagnóstico de DT2 y CaMa.

"Introducción: diversas investigaciones han evaluado el riesgo de cáncer de mama (CaMa) asociado a diabetes tipo 2 (DT2) con resultados inconsistentes. Pocas investigaciones han evaluado el porcentaje de riesgo atribuible a la población (PAR%). Objetivo: estimar la asociación y el PAR% para CaMa por DT2, así como los factores del estilo de vida y ginecológicos en mujeres de la Ciudad de México. Métodos: estudio de casos y controles, realizado de mayo a diciembre de 2020. Se incluyeron mujeres > 40 años, de la Ciudad de México, con diagnóstico confirmado de CaMa. Los controles fueron mujeres con una mastografía BIRADS 1 o 2, o ultrasonido mamario sin datos sugestivos de CaMa. Resultados: se incluyeron en total 134 casos y 134 controles. Se identificó un mayor riesgo de CaMa en aquellas mujeres que no realizan actividad física y con el uso de anticonceptivos > 5 años. El uso de terapia de reemplazo hormonal (TRH) se asoció con una razón de momios ajustada (RMa) de 5.0, p = 0.22 en el modelo 1. Conforme se ajustan los modelos, la TRH para el modelo 2 tuvo una RMa de 2.92, p = 0.492 y en el modelo 3 una RMa de 3.6 p = 0.753. La presencia de diabetes se asoció a una RMa de 1.04, p = 0.96 en el modelo 1; RMa de 0.65, p = 0.65 en el modelo 2 y una RMa de 0.75, p = 0.79 en el modelo 3. Conclusiones: en este estudio de casos y controles no se encontró asociación entre el diagnóstico de DT2 y CaMa."